Hartford Large Cap Growth ETF Q4 2025 Commentary

The Hartford Large Cap Growth ETF underperformed the Russell 1000 Growth Index during the quarter while still delivering overall positive returns; security selection was the primary driver of the relative underperformance. Weak selection in information technology and communication services weighed on relative returns, partially offset by selection in healthcare and industrials, and sector allocation contributed modestly to returns as a byproduct of bottom-up stock selection.

Analysis

Active-manager stock selection divergences tend to produce predictable flow and dispersion patterns: when bottom-up managers underweight or mis-time large-cap tech and comms exposure, passive vehicles and concentrated mega-cap holders pick up incremental inflows, while specialist managers (healthcare, industrials) can harvest re-rating opportunities. Second-order supply-chain effects are non-linear — a sustained pause in IT/communications capex over 1–3 quarters tends to hit semiconductor equipment OEMs and cloud-infrastructure suppliers first, then software vendors in the following 2–4 quarters as renewal and seat-add momentum slows.

Key catalysts to watch across time horizons: near term (30–90 days) earnings guides and ad-revenue prints can rapidly reverse sentiment into tech/comm names; medium term (3–9 months) Fed rate trajectory and corporate buyback pace will reweight growth vs. quality; long term (12–24 months) durable secular winners in AI/healthcare M&A will reassert valuations regardless of transient flow dynamics. Tail risks include a rapid lump-sum outflow from active funds forcing liquidations (weeks) and a crowded long in a subset of discounted growth names producing squeeze dynamics on short covering (days–weeks).

The consensus is treating recent dispersion as a structural death of growth rather than a rotational pricing event; that overstates permanent impairment and understates optionality embedded in cash-rich large caps and biotech/healthcare franchises. The asymmetric opportunity is to harvest sector-selection alpha through relative-value trades and event-driven option structures that monetize short-term fear while keeping upside to a normalization in tech capex and ad recovery over 3–12 months.

Key Decisions for Investors

• Pair trade (3–6 months): Long XLV (healthcare ETF) / Short XLK (tech ETF) equal notional. Target 5–8% relative return if healthcare selection continues to outperform; stop-loss if pair moves against you by 3% to limit drawdown. Rationale: capitalizes on selection-driven sector rotation while limiting market beta.
• Event-driven options hedge (0–3 months): Buy a 3-month ATM put spread on XLK (sell 1 OTM put for premium offset). Break-even ~8–10% downside in XLK; max loss limited to premium. Use this as protection against earnings-driven downside in tech/comm while preserving upside participation.
• Selective long (6–12 months): Overweight industrials via XLI or 2–3 individual names with cyclical order-book visibility (target 6–12% absolute upside). Size modestly (1–2% NAV) and take profits on a 10%+ move. Rationale: industrial selection benefits from cyclical repair and avoids single-name tech volatility.
• Convex healthcare play (9–18 months): Buy IBB call spreads (OTM, 12–18 month expiries) to express idiosyncratic biotech/medtech rerating at defined cost. Expect >2x payoff if sector resumes earnings or M&A-driven rerate; max loss limited to premium paid.